Live Breaking News & Updates on Amyloidosis Centre|Page 5
Stay updated with breaking news from Amyloidosis centre. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SPONSORED CONTENT: Morie Gertz, MD, reviews data on the use of birtamimab plus standard-of-care anti-plasma cell chemotherapy in patients with light-chain amyloidosis, which was investigated in the phase 3 randomized, placebo-controlled VITAL trial. ....
In a complete response letter, the FDA said the clinical meaningfulness of patisiran s effects in cardiomyopathy of ATTR amyloidosis are not established, despite good reviews from an advisory panel. ....